Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

7432 Bicistronic_GFP_ires_puro Citations (1)

Originally described in: Mutant KRAS promotes malignant pleural effusion formation.
Agalioti T, Giannou AD, Krontira AC, Kanellakis NI, Kati D, Vreka M, Pepe M, Spella M, Lilis I, Zazara DE, Nikolouli E, Spiropoulou N, Papadakis A, Papadia K, Voulgaridis A, Harokopos V, Stamou P, Meiners S, Eickelberg O, Snyder LA, Antimisiaris SG, Kardamakis D, Psallidas I, Marazioti A, Stathopoulos GT Nat Commun. 2017 May 16;8:15205. doi: 10.1038/ncomms15205.
PubMed Journal

Articles Citing 7432 Bicistronic_GFP_ires_puro

Articles
An In Vivo Inflammatory Loop Potentiates KRAS Blockade. Arendt KAM, Ntaliarda G, Armenis V, Kati D, Henning C, Giotopoulou GA, Pepe MAA, Klotz LV, Lamort AS, Hatz RA, Kobold S, Schamberger AC, Stathopoulos GT. Biomedicines. 2022 Mar 3;10(3). pii: biomedicines10030592. doi: 10.3390/biomedicines10030592. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.